Cargando…

An intraductal approach to breast cancer risk assessment and screening in a diverse population

Detalles Bibliográficos
Autores principales:	Bailey, L, Greif, J, Mandelke, J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2727098/ http://dx.doi.org/10.1186/1753-6561-3-S5-S24

Ejemplares similares

Intraductal assessment to determine response to chemopreventive interventions
por: Sauter, ER
Publicado: (2009)

Intraductal micro magnetic resonance imaging and spectroscopy
por: Strick, D, et al.
Publicado: (2009)

State of the Science and the Intraductal Approach for Breast Cancer: Proceedings Summary of The Sixth International Symposium on the Intraductal Approach To Breast Cancer Santa Monica, California, 19–21 February 2009
por: Rochman, Susan, et al.
Publicado: (2009)

A phase 1 study assessing the feasibility and safety of intraductal pegylated liposomal doxorubicin (PLD) in women awaiting mastectomy
por: Stearns, V, et al.
Publicado: (2009)

Screening with Magnetic Resonance Imaging in women at low and intermediate risk of breast Cancer
por: Huzarski, T T, et al.
Publicado: (2012)

Intraductal therapy of DCIS with liposomal doxorubicin: a preoperative trial in rural California
por: Mahoney, ME, et al.
Publicado: (2009)

Histopathological responses to a short term intraductal cytotoxic agent treatment: results of a feasibility study
por: Rao, J, et al.
Publicado: (2009)

The Fourth International Symposium on the Intraductal Approach to Breast Cancer, Santa Barbara, California, 10–13 March 2005
por: King, Bonnie L, et al.
Publicado: (2005)

Breast ultrasound in a "moderate risk" population
por: O'Driscoll, D, et al.
Publicado: (2000)

Assessing performance of screen readers in the National Health Service Breast Screening Programme (NHSBSP)
por: Liston, JC
Publicado: (2002)

Stages of screen-detected breast cancer
por: Koufopoulos, K, et al.
Publicado: (2000)

State-wide population screening for Lynch syndrome? Improved ascertainment of at risk families
por: Goldblatt, J, et al.
Publicado: (2012)

Are too many breast cancers missed at assessment?
por: Liston, J
Publicado: (2000)

Oncogenic viruses in nipple aspirate fluid: biomarkers for breast cancer risk assessment?
por: Baltzell, K, et al.
Publicado: (2009)

Screening and its effect on breast cancer mortality rates
por: Blanks, RG
Publicado: (2000)

Screening breast cancer patients for Norwegian ATM mutations
por: Laake, K, et al.
Publicado: (2000)

Genetic insights into breast cancer risk
por: Wong-Brown, Michelle, et al.
Publicado: (2015)

A review of screen detected breast cancers among aboriginal women in Western Australia
por: Wylie, EJ, et al.
Publicado: (2002)

An audit of benign biopsies performed in patients assessed by the Leeds/Wakefield Breast Screening Unit
por: Carder, PJ, et al.
Publicado: (2002)

Community navigators for breast and cervical cancer screening and follow-up
por: Simon, Melissa A, et al.
Publicado: (2015)

Arsenic (As) and breast cancer risk
por: Muszyńska, Magdalena, et al.
Publicado: (2012)

Iron and breast cancer risk
por: Sukiennicki, Grzegorz, et al.
Publicado: (2012)

Zinc and breast cancer risk
por: Kaczmarek, Katarzyna, et al.
Publicado: (2012)

Intraductal pegylated liposomal doxirubicin may achieve long term protection in HER2/NEU transgenic mice by restricting mammary gland outgrowth
por: Sukumar, S, et al.
Publicado: (2009)

Anatomical association of fluid yielding ducts with location of the breast cancer affected segment in screen detected and symptomatic breast cancer
por: Gui, GPH, et al.
Publicado: (2009)

Common genomic variants associated with breast cancer predict the risk of second primary breast cancer diagnosis
por: Sawyer, S, et al.
Publicado: (2012)

Folic acid and breast cancer risk
por: Durda, Katarzyna, et al.
Publicado: (2012)

Selenium (Se) and breast cancer risk
por: Jaworska - Bieniek, Katarzyna, et al.
Publicado: (2012)

Welcome to North Wales breast screening
por: Thomas, W
Publicado: (2002)

Recording breast screening decisions: human factors and new technology
por: Hatton, J, et al.
Publicado: (2002)

Heterocyclic amines (HCAS) and risk of breast cancer
por: Sinha, R, et al.
Publicado: (2001)

GWAS markers in diagnostics of breast cancer risk
por: Jakubowska, Anna
Publicado: (2012)

Imaging methods to screen women with breast implants
por: Morrow, M
Publicado: (2000)

Prostate cancer screening based on genotyping for high risk founder alleles
por: Cybulski, Cezary, et al.
Publicado: (2012)

Provider payment approaches and incentives to implement screening
por: Horgan, Constance M, et al.
Publicado: (2013)

Does preoperative diagnosis reduce the number of operations required for treatment of screen-detected breast cancer?
por: Ralleigh, G, et al.
Publicado: (2000)

Rapid test for detection of high risk of breast cancer
por: Durda, K, et al.
Publicado: (2012)

Selenium (Se) and the risk of breast, ovarian and prostate cancers
por: Jaworska, Katarzyna, et al.
Publicado: (2012)

Risk-reducing surgery for breast and ovarian cancer risks - where are we now?
por: Hallowell, N, et al.
Publicado: (2012)

Validation study of risk prediction models for female relatives of Australian women with breast cancer
por: MacInnis, R, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_77f8cdhvdj9qrbtsl28qfrlqah